AnnJi Pharmaceutical Co. is a clinical-stage company focusing on the development of neurological dermatological therapeutics. AnnJi will participate in virtual one-on-one meetings at Digital Bio 2021 held virtually from June 14-18, 2021. The company’s presentation video will be available during the event; featuring AnnJi’s leading assets in the pipeline; such as Nrf2 activator for PolyQ diseases and selective HDAC6 inhibitor for peripheral neuropathy and fibrotic disease.